Change over period: —
NSE · NH
NH
-9.1% from the 52-week high · +17.8% above the low
Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka and currently employs 11,726 full-time employees. The company went IPO on 2016-01-06. The firm operates a network of hospitals, diagnostic centers, clinical centers or test laboratories. The firm operates through Medical and Healthcare Services business segment. The firm offers medical, surgery, and diagnostics and support services. The company provides services in the areas of cardiology; orthopedics; cosmetic surgery; anesthesia; imaging and radiology; nutrition and dietetics; physiotherapy; renal transplant; thoracic surgery; pediatrics surgery; medical oncology; surgical gastroenterology; dermatology; hematology; rheumatology; neurology; psychiatry and psychology, and others. The firm operates a network of approximately 20 hospitals (multispecialty and super specialty healthcare facilities), four heart centers and 19 primary care facilities (including clinics and information centers), across India and a hospital at Cayman Islands with approximately 6,181 operational beds.
The short version. NH reported revenue of ₹2,844 crore for Sep 2026, up 73.0% from a year earlier. Net profit was ₹301 crore (up 16.7% year on year). Return on equity was 17.8% in Mar 2026. Promoter holding was 63.27% in Sep 2026, down 0.58 points over 8 quarters.
1 · The price
How has the stock traded?
NH trades 9.1% below its 52-week high and 17.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹2,844 cr.
Sep 2026 net profit of ₹301 cr.
5.1 pts lower than a year earlier.
Revenue compounded at 20.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2844 | 2684 | 2594 | 2151 | 1644 | 1507 | 1475 | 1367 |
| Net profit | 301 | 207 | 224 | 127 | 258 | 197 | 197 | 193 |
| Net margin % | 10.6 | 7.7 | 8.6 | 5.9 | 15.7 | 13.0 | 13.4 | 14.1 |
| EPS (₹) | 14.73 | 10.14 | 10.96 | 6.2 | 12.64 | 9.62 | 9.65 | 9.44 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7896 | 5483 | 5018 | 4525 | 3701 | 2582 | 3128 | 2861 |
| Net profit | 806 | 790 | 789 | 606 | 342 | -14 | 119 | 59 |
| Net margin % | 10.2 | 14.4 | 15.7 | 13.4 | 9.2 | -0.6 | 3.8 | 2.1 |
| EPS (₹) | 39.42 | 38.66 | 38.62 | 29.67 | 16.73 | -0.7 | 5.82 | 2.9 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 17.8% in Mar 2026; debt to equity is 1.07.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 17.8 | 21.8 | 27.4 | 28.4 |
| Return on capital % | 11.4 | 17.7 | 21.8 | 25.9 |
| EBITDA margin % | 20.8 | 24.4 | 24.1 | 22.5 |
| Net margin % | 10.1 | 14.2 | 15.5 | 13.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 20.3% | 25.1% |
| Profit CAGR | 9.9% | — |
4 · The owners
Who holds it, and are they adding?
Down 0.58 pts over 8 quarters.
Down 0.43 pts over 8 quarters.
Up 1.99 pts over 8 quarters.
+26 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.85 | 63.85 | 63.85 | 63.85 | 63.27 | 63.27 | 63.27 | 63.27 | -0.58 |
| FII | 9.44 | 9.66 | 10.46 | 10.49 | 11.1 | 9.98 | 9.4 | 9.01 | -0.43 |
| DII | 8.69 | 8.52 | 8.09 | 7.76 | 7.91 | 9.15 | 9.06 | 10.68 | +1.99 |
| Public | 17.4 | 17.35 | 16.98 | 17.29 | 17.1 | 16.98 | 17.65 | 16.42 | -0.98 |
Mutual fund holdings · Oct 2026
118 schemes hold this stock
92 the month before.
- Groww BSE Hospitals ETF5.51% of NAV
- Bandhan Healthcare Fund3.18% of NAV
- Taurus Elss Tax Saver Fund3.04% of NAV
- Mirae Asset Midcap Fund2.12% of NAV
- the Quantum ESG Best In Class Strategy Fund1.92% of NAV
- WhiteOak Capital Pharma and Healthcare Fund1.87% of NAV
- Groww Value Fund1.87% of NAV
- ADITYA BIRLA SUN LIFE BUSINESS CYCLE FUND1.8% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for NH are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about NH
What is the NH share price?
NH (NH) last closed at ₹1,873.10, down 0.96% on the day. Its 52-week range is ₹1,605.30 to ₹2,080.30.
What is the market cap of NH?
NH has a market capitalisation of about ₹38,397 crore. Its price-to-earnings ratio is 44.7.
How are NH's latest results?
NH reported revenue of ₹2,844 crore for Sep 2026, up 73.0% from a year earlier. Net profit was ₹301 crore (up 16.7% year on year). Return on equity was 17.8% in Mar 2026. Promoter holding was 63.27% in Sep 2026, down 0.58 points over 8 quarters.
Who owns NH?
As of Sep 2026, shareholding was: Promoter 63.27%, FII 9.01%, DII 10.68%, Public 16.42%.
How many mutual funds hold NH?
118 mutual fund schemes held NH in October 2026. That compares with 92 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 01 Aug 2025 · Final Dividend - Rs. 4.5
- 02 Aug 2024 · Dividend - Rs. 4
- 07 Jul 2023 · Final Dividend - Rs. 2.5
- 22 Aug 2022 · Final Dividend - Rs. 1
- 11 Mar 2020 · Interim Dividend - Rs. 1
- 01 Aug 2019 · Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.